[Lifeline, A Musical That Raises The Alarm On Antimicrobial Resistance](https://wbbsec.com/opinions-and-features/lifeline-a-musical-that-raises-the-alarm-on-antimicrobial-resistance/)
[Lifeline, A Musical That Raises The Alarm On Antimicrobial Resistance](https://wbbsec.com/opinions-and-features/lifeline-a-musical-that-raises-the-alarm-on-antimicrobial-resistance/)
In: Press Releases

For Immediate Release

May 16, 2023

Cranford, NJ –  WBB Securities will be sponsoring a Demy-Colton Virtual Salon (webinar) on May 17, 2023, beginning at 11:00 am ET titled “Candida Auris: Ignore it and Other Emerging Pathogens at Your Own Risk!”

Registration for this event is FREE at: https://bit.ly/42lO4fG

Emerging pathogens are an increasing threat because most treatments for them are failing. Repeated warnings about the likelihood of a pandemic event worse than COVID-19 have been issued by governing bodies, research organizations, and prominent leaders in the healthcare arena, but coordinated responses have yet to be developed.

This webinar will provide answers and first steps to meeting the emerging pathogen challenge from some of the most highly regarded people in the quest to meet this emerging threat.

About WBB Securities.

WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily in the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of FINRA, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.

www.wbbsec.com 

About Demy-Colton.

Demy Colton is a leader in biotech and life science events, with over 20 years of experience connecting leaders of innovative biotech companies with key stakeholders, investors, and advisors, we create ideal environments to examine and address opportunities and challenges in today’s biotech industry.

www.demy-colton.com